Aligned Genetics

얼라인드 · 238120

Information Technology Components · KOSDAQ

Small-cap

Market cap US$36.2M (₩49.9B)

Overview

Aligned Genetics makes laboratory instruments for life-science research and diagnostics, including automated cell counters, biological-tissue clearing and imaging systems, and digital cell imaging systems that replace traditional analogue microscopes.

Its customers span research laboratories, academic institutions, and healthcare organisations worldwide. Listed on KOSDAQ, Korea's tech-focused small-cap exchange, the company offers three distinct product lines that together cover cell analysis, three-dimensional tissue imaging, and digital microscopy.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$11.6M
▲ +1.5% YoY
Operating profit · FY2025
US$1.8M
▼ −12.1% YoY
Net income · FY2025
US$2.1M
▼ −29.5% YoY

Revenue

  • FY2023US$11M
  • FY2024US$11.4M
  • FY2025US$11.6M

Operating profit

  • FY2023US$2.4M
  • FY2024US$2M
  • FY2025US$1.8M

Net income

  • FY2023US$2.3M
  • FY2024US$3M
  • FY2025US$2.1M

Key ratios (FY2025)

ROE
7.8%
Debt/Eq
55.5%
Op. margin
15.3%
Net margin
18.2%
Rev. YoY
▲ +1.5%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.